Announcements Trials
Browse Landscape

Phase

Phase 3 4

Status

Completed 4

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Conditions

Leiomyoma 4Menorrhagia 2

Interventions

Paclitaxel 490Carboplatin 436Gemcitabine 394Docetaxel 385Cisplatin 360pembrolizumab 344Bevacizumab 335Nivolumab 261Pemetrexed 243Capecitabine 221Dexamethasone 213Fluorouracil 211Rituximab 203Trastuzumab 193Cyclophosphamide 190Oxaliplatin 160Erlotinib Hydrochloride 147Ipilimumab 145atezolizumab 144Prednisone 144Cetuximab 142Irinotecan 139Leucovorin 130Doxorubicin 130Sorafenib 120Lenalidomide 119Bortezomib 118Sunitinib 107Everolimus 93130-nm albumin-bound paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × INDUSTRY × linzagolix × Clear all
NCT05445167 2025-11-25

A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain

Kissei Pharmaceutical Co., Ltd.

Phase 3 Completed
89 enrolled

Leiomyoma

NCT05440383 2025-03-14

A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia

Kissei Pharmaceutical Co., Ltd.

Phase 3 Completed
287 enrolled

Leiomyoma

NCT03070899 2021-06-09

PRIMROSE 1

ObsEva SA

Phase 3 Completed
526 enrolled

Leiomyoma, Menorrhagia

NCT03070951 2021-03-05

PRIMROSE 2

ObsEva SA

Phase 3 Completed
511 enrolled

Leiomyoma, Menorrhagia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡